XERS
Xeris Biopharma Holdings, Inc.
NASDAQ · USHealthcareBiotechnology
$8.78-0.28%
Price as of Jul 20, 2026
XERS ownership
Xeris Biopharma Holdings, Inc. ownership & insider activity
Latest available institutional positioning and SEC Form 4 insider transactions, coalesced at the company entity level when listings share coverage.
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
10
Net (3m)
-$1.8M
Insider trades by month Buys Sells
Feb
Mar
Apr
May
Jun
Jul
Context3-month price +40.8%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 7, 2026 | Pieper Stevenofficer: See Remarks | Sell | 17,400 | $8.50 |
| Jul 7, 2026 | Pieper Stevenofficer: See Remarks | Sell | 27,600 | $8.52 |
| Jul 2, 2026 | KREHER NERISSAdirector | Grant | 33,582 | — |
| Jul 2, 2026 | KREHER NERISSAdirector | Grant | 37,910 | $8.00 |
| Jul 2, 2026 | McCulloch Kevinofficer: See Remarks | Sell | 90,000 | $8.03 |
| Jul 2, 2026 | Hecht Bethofficer: See Remarks | Sell | 16,666 | $8.03 |
| Jun 5, 2026 | PERSKY MARLAdirector | Grant | 32,996 | $6.15 |
| Jun 5, 2026 | HALKUFF DAWNdirector | Sell | 20,000 | $6.09 |
| Jun 5, 2026 | JOHNSON JOHNdirector | Grant | 24,193 | — |
| Jun 5, 2026 | JOHNSON JOHNdirector | Sell | 15,000 | $6.09 |
| Jun 5, 2026 | BORMANN-KENNEDY BARBARA-JEAN ANNEdirector | Grant | 32,996 | $6.15 |
| Jun 5, 2026 | BORMANN-KENNEDY BARBARA-JEAN ANNEdirector | Grant | 24,193 | — |
| Jun 5, 2026 | BORMANN-KENNEDY BARBARA-JEAN ANNEdirector | Sell | 16,000 | $6.09 |
| Jun 5, 2026 | HALKUFF DAWNdirector | Grant | 32,996 | $6.15 |
| Jun 5, 2026 | HALKUFF DAWNdirector | Grant | 24,193 | — |
| Jun 5, 2026 | PERSKY MARLAdirector | Sell | 15,500 | $5.90 |
| Jun 5, 2026 | Kong Garhengdirector | Grant | 24,193 | — |
| Jun 5, 2026 | Kong Garhengdirector | Grant | 32,996 | $6.15 |
| Jun 5, 2026 | PERSKY MARLAdirector | Grant | 24,193 | — |
| Jun 5, 2026 | Brady James Aloysiusdirector | Grant | 32,996 | $6.15 |
| Jun 5, 2026 | Brady James Aloysiusdirector | Grant | 24,193 | — |
| Jun 5, 2026 | JOHNSON JOHNdirector | Grant | 32,996 | $6.15 |
| Jun 2, 2026 | Hecht Bethofficer: See Remarks | Sell | 16,667 | $6.06 |
| May 1, 2026 | Hecht Bethofficer: See Remarks | Sell | 16,667 | $6.23 |
| Apr 3, 2026 | Hecht Bethofficer: See Remarks | Sell | 16,667 | $5.99 |
| Apr 1, 2026 | Brady James Aloysiusdirector | Sell | 10,834 | $5.54 |
| Mar 16, 2026 | McCulloch Kevinofficer: See Remarks | Option | 48,894 | $4.09 |
| Mar 16, 2026 | McCulloch Kevinofficer: See Remarks | Option | 4 | $3.94 |
| Mar 5, 2026 | Pieper Stevenofficer: See Remarks | Option | 27,891 | $4.09 |
| Mar 5, 2026 | Pieper Stevenofficer: See Remarks | Option | 14,036 | $5.93 |
Source: XERS SEC Form 4 filings, latest Jul 7, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their XERS positions over the last 6 months (SEC Form 13F).
Increased
186
New positions
79
Reduced
133
Sold out
78
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Increased | 12.9M | May 13, 2026 |
| BLACKROCK, INC. | Increased | 12.6M | Feb 12, 2026 |
| VANGUARD GROUP INC | Increased | 11.2M | Jan 29, 2026 |
| D. E. SHAW & CO., INC. | Increased | 7.8M | May 15, 2026 |
| D. E. SHAW & CO., INC. | Increased | 7.6M | Feb 17, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 7.0M | May 15, 2026 |
| STATE STREET CORP | Increased | 4.7M | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 4.3M | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 4.3M | Feb 9, 2026 |
| STATE STREET CORP | Increased | 4.1M | Feb 13, 2026 |
| QUBE RESEARCH & TECHNOLOGIES LTD | Increased | 4.1M | May 15, 2026 |
| QUBE RESEARCH & TECHNOLOGIES LTD | Increased | 3.5M | Feb 17, 2026 |
| ROSALIND ADVISORS, INC. | Increased | 3.2M | May 14, 2026 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | Increased | 3.0M | Feb 17, 2026 |
| NUVEEN, LLC | Increased | 2.9M | Apr 30, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.